Mizuho Initiates Coverage of Molecular Tools Vendors | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mizuho Securities has initiated coverage on five molecular tools firms, adding to a number of molecular diagnostics firms the investment bank began covering last month.

After the close of the market on Monday, Mizuho announced in separate reports it was covering Illumina, Life Technologies, Waters, Thermo Fisher Scientific, and Sigma-Aldrich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.